NEW YORK – Chromatography firm PharmaFluidics said Tuesday that it has been awarded a €613,000 ($686,250) grant from Flanders’ Innovation & Entrepreneurship Agency (VLAIO).
The two-year grant will support Ghent, Belgium-based PharmaFluidics' work in optimizing its liquid chromatography manufacturing process and in developing new chromatography products based on its µPAC technology.
"The funding will allow us to build proprietary process know-how and allow PharmaFluidics to further advance the reproducibility and reliability of our micro-chip based µPAC nano, capillary, and micro-LC columns, which are already amongst their distinguishing features” Paul Jacobs, PharmaFluidics’ COO, said in a statement.
PharmaFluidics' µPAC columns use freestanding pillars etched onto a silicon wafer to separate samples. According to the company, this allows it to create columns with ordered and consistent separation structures, eliminating the randomness inherent in traditional packed particle-based approaches, thereby providing sharper LC peaks.